Transparency in COVID-19 Vaccine Procurement

by name voted on 21.10.2021

Summary

This motion calls for greater transparency regarding the European Union's purchase and distribution of COVID-19 vaccines, demanding full disclosure of contracts and clinical data.

9 21.10.2021

Other

budget

health

social policy

european union

administrative law

public administration

Key points

The motion demands the publication of non-redacted versions of vaccine purchase agreements to ensure public accountability.
It highlights that the EU's vaccination campaign lagged behind other regions like the UK, USA, and Israel.
The resolution calls for the disclosure of specific details, including price per dose, allocation per Member State, and liability regimes.
It requires that full clinical trial results and patient-level data be made available to independent scientific experts.

Vote

PPE

S&D

Renew

Verts/ALE

ID

ECR

The Left

NI

Total

Speeches

5 Speeches in total

Pro

Contra

Othmar KARAS

PPE

1:16 min

19. Second voting session

Othmar KARAS

PPE

0:40 min

5. First voting session

Documents (PDFs)

MOTION FOR A RESOLUTION on EU transparency in the development, purchase and distribution of COVID-19 vaccines MOTION FOR A RESOLUTION on EU transparency in the development, purchase and distribution of COVID-19 vaccines EU transparency in the development, purchase and distribution of COVID-19 vaccines

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.